HONG KONG – The heavily oversubscribed Hong Kong IPO by Wuxi Biologics, is underscoring a promising outlook for biotech companies in Asia.

HONG KONG – Saudi Arabia is emerging as a powerhouse for drug production.

HONG KONG – Saudi Arabia is emerging as a powerhouse for drug production. Case in point is a newly built 75,000-square-meter drug manufacturing facility in the country’s King Abdulla Economic City.

HONG KONG – Sanofi Pasteur Ltd.'s dengue vaccine has been granted a conditional registration for two years in Malaysia while phase IV studies are carried out.

HONG KONG – Sanofi Pasteur Ltd.'s dengue vaccine has been granted a conditional registration for two years in Malaysia while phase IV studies are carried out.